AAAAAA

   
Results: 1-10 |
Results: 10
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors
Authors: Le Moing, V Chene, G Carrieri, MP Besnier, JM Masquelier, B Salamon, R Bazin, C Moatti, JP Raffi, F Leport, C
Citation: V. Le Moing et al., Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors, J ACQ IMM D, 27(4), 2001, pp. 372-376
Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection
Authors: Leibenguth, P Le Guellec, C Besnier, JM Bastides, F Mace, M Gaudet, ML Autret-Leca, E Paintaud, G
Citation: P. Leibenguth et al., Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection, THER DRUG M, 23(6), 2001, pp. 679-688
The VIRGO Study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults
Authors: Raffi, F Reliquet, V Ferre, V Arvieux, C Hascoet, C Bellein, V Besnier, JM Breuz, JP Garre, M May, T Molina, JM Perre, P Raguin, G Rozenbaum, W Zucman, D
Citation: F. Raffi et al., The VIRGO Study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults, ANTIVIR TH, 5(4), 2000, pp. 267-272
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients
Authors: Piroth, L Grappin, M Cuzin, L Mouton, Y Bouchard, O Raffi, F Rey, D Peyramond, D Gourdon, F Drobacheff, C Lombart, ML Lucht, F Besnier, JM Bernard, L Chavanet, P Portier, H
Citation: L. Piroth et al., Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients, J VIRAL HEP, 7(4), 2000, pp. 302-308
Clubbing associated with primary alveolar proteinosis: possible implication of growth factors
Authors: Hazouard, E Jacquemain, C Rivoire, B Besnier, JM de Muret, A Diot, P
Citation: E. Hazouard et al., Clubbing associated with primary alveolar proteinosis: possible implication of growth factors, PRESSE MED, 29(18), 2000, pp. 999-999
The effect of RMO/medical guidelines based on a critical assessment of antibiotic drug prescription.
Authors: Choutet, P Crochet, B Chahwakilian, P Bastides, F Guimard, Y Correze, JR Besnier, JM
Citation: P. Choutet et al., The effect of RMO/medical guidelines based on a critical assessment of antibiotic drug prescription., MED MAL INF, 30, 2000, pp. 185S-192S
Plant alternatives
Authors: Besnier, JM
Citation: Jm. Besnier, Plant alternatives, BIOFUTUR, 2000(205), 2000, pp. 17-17
Mucocutaneous leishmaniasis of the nose and tongue
Authors: Petorin, C Bastides, F Payard, J Guimard, Y Besnier, JM Choutet, P
Citation: C. Petorin et al., Mucocutaneous leishmaniasis of the nose and tongue, REV MED IN, 21, 2000, pp. 358S-359S
Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients
Authors: Reliquet, V Ferre, V Hascoet, C Besnier, JM Bellein, V Arvieux, C Molina, JM Breux, JP Zucman, D Rozenbaum, W Allavena, C Raffi, F
Citation: V. Reliquet et al., Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients, ANTIVIR TH, 4, 1999, pp. 83-84
Infections involving protheses: From adherences to biofilms. Fundamental aspects
Authors: Besnier, JM
Citation: Jm. Besnier, Infections involving protheses: From adherences to biofilms. Fundamental aspects, REV CHIR OR, 84, 1998, pp. 67-67
Risultati: 1-10 |